News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

U.S. Approves Treatment For DynPort Vaccine Company LLC's Smallpox Shot Reaction



10/19/2005 5:12:47 PM

WASHINGTON (Reuters) - A product taken from the blood of people who have been vaccinated for smallpox was approved on Friday to use to treat reactions from the shot, the U.S. Food and Drug Administration said. The FDA said it had approved DynPort Vaccine Co. LLC's Vaccinia Immune Globulin Intravenous. It is made out of human plasma.

Read at Reuters
Read at FDA
Read at News-Medical
Read at PharmaBiz


comments powered by Disqus
Reuters
FDA
News-Medical
PharmaBiz
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES